Menu Search
Equities

Samarkand Group PLC

7FX:STU

Samarkand Group PLC

Actions
  • Price (--)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
--
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Samarkand Group plc is a United Kingdom-based consumer brand owner and cross-border e-commerce distribution services company. The Company is engaged in operating a scale-up platform for niche, premium, multichannel, health and healing brands. Its core owned brands include Napiers the Herablists, Scotland's oldest natural herbal apothecary, Zita West, a specialist supplement line for fertility and reproductive health and Probio7, a probiotic supplements brand. The Company’s platform services include marketing, sales and channel development with a focus on social commerce, China market entry, international expansion and manufacturing. In addition, the Company works as the exclusive China market partner for a select portfolio of niche luxury skin care brands and connects these brands to the Chinese consumer via cross-border e-commerce, leveraging its Nomad technology. Its solutions include Nomad Checkout, Nomad Storefront and Nomad Distribution.

  • Revenue in GBP (TTM)17.35m
  • Net income in GBP-5.48m
  • Incorporated2021
  • Employees85.00
  • Location
    Samarkand Group PLCUnit 13 & 14 Nelson Trading EstateThe PathLONDON SW19 3BLUnited KingdomGBR
  • Phone+44 203 740 3933
  • Websitehttps://www.samarkand.global/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.